学术探索
学术期刊
新闻热点
数据分析
智能评审

Medical progress - Cardiovascular risk and body-fat abnormalities in HIV-infected adults.

被引：789
作者：
Grinspoon, S
Carr, A
机构：
[1] Massachusetts Gen Hosp, Program Nutr Metab, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Neuroendocrine Unit, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] St Vincents Hosp, HIV Immunol & Infect Dis Clin Serv Unit, Sydney, NSW 2010, Australia
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2005年 / 352卷 / 01期
关键词：
D O I：
10.1056/NEJMra041811
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：48 / 62
页数：15
相关论文
共 100 条
  • [71] A randomized, double-blind study of gemfibrozil for the treatment of protease inhibitor-associated hypertriglyceridaemia
    Miller, J
    Brown, D
    Amin, J
    Kent-Hughes, J
    Law, M
    Kaldor, J
    Cooper, DA
    Carr, A
    [J]. AIDS, 2002, 16 (16) : 2195 - 2200
  • [72] Miller J, 2003, HIV Med, V4, P293
  • [73] Cardio- and cerebrovascular events in HIV-infected persons
    Monforte, AD
    Sabin, CA
    Phillips, AN
    Reiss, P
    Weber, R
    Kirk, O
    El-Sadr, W
    De Wit, S
    Mateu, S
    Petoumenos, K
    Dabis, F
    Pradier, C
    Morfeldt, FL
    Lundgren, JD
    Friis-Moller, N
    Collins, S
    Loeliger, E
    Tressler, R
    Weller, I
    Sawitz, A
    Rickenbach, M
    Pezzotti, P
    Krum, E
    Zaheri, S
    Lavignolle, V
    Sundström, A
    Poll, B
    Fontas, E
    Torres, F
    Kjær, J
    [J]. AIDS, 2004, 18 (13) : 1811 - 1817
  • [74] A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection
    Moyle, GJ
    Lysakova, L
    Brown, S
    Sibtain, N
    Healy, J
    Priest, C
    Mandalia, S
    Barton, SE
    [J]. HIV MEDICINE, 2004, 5 (02) : 82 - 87
  • [75] A 48-week, randomized, open-label comparison of three Abacavir-based substitution approaches in the management of dyslipidemia and peripheral lipoatrophy
    Moyle, GJ
    Baldwin, C
    Langroudi, B
    Mandalia, S
    Gazzard, BG
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 33 (01) : 22 - 28
  • [76] Dietary advice with or without pravastatin for the management of hypercholesterolaemia associated with protease inhibitor therapy
    Moyle, GJ
    Lloyd, M
    Reynolds, B
    Baldwin, C
    Mandalia, S
    Gazzard, BG
    [J]. AIDS, 2001, 15 (12) : 1503 - 1508
  • [77] The mechanism of insulin resistance caused by HIV protease inhibitor therapy
    Murata, H
    Hruz, PW
    Mueckler, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (27) : 20251 - 20254
  • [78] Dose-ranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in anti retroviral-naive subjects: 48-week results
    Murphy, RL
    Sanne, I
    Cahn, P
    Phanuphak, P
    Percival, L
    Kelleher, T
    Giordano, M
    [J]. AIDS, 2003, 17 (18) : 2603 - 2614
  • [79] Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine
    Negredo, E
    Ribalta, J
    Paredes, R
    Ferré, R
    Sirera, G
    Ruiz, L
    Salazar, J
    Reiss, P
    Masana, L
    Clotet, B
    [J]. AIDS, 2002, 16 (10) : 1383 - 1389
  • [80] Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy
    Nolan, D
    Hammond, E
    Martin, A
    Taylor, L
    Herrmann, S
    McKinnon, E
    Metcalf, C
    Latham, B
    Mallal, S
    [J]. AIDS, 2003, 17 (09) : 1329 - 1338
12345678910